Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics

The respiratory syncytial virus (RSV) fusion protein F is considered an attractive vaccine candidate especially in its prefusion conformation. We studied whether recombinant soluble RSV F proteins could be stabilized in a prefusion-like conformation by mutation of heptad repeat B (HRB). The results show that soluble, trimeric, non-cleaved RSV F protein, produced by expression of the furin cleavage site-mutated F ectodomain extended with a GCN4 trimerization sequence, is efficiently recognized by pre- as well as postfusion-specific antibodies. In contrast, a similar F protein completely lacking HRB displayed high reactivity with prefusion-specific antibodies recognizing antigenic site Ø, but did not expose postfusion-specific antigenic site I, in agreement with this protein maintaining a prefusion-like conformation. These features were dependent on the presence of the GCN4 trimerization domain. Absence of cleavage also contributed to binding of prefusion-specific antibodies. Similar antibody reactivity profiles were observed when the prefusion form of F was stabilized by the introduction of cysteine pairs in HRB. To study whether the inability to form the 6HB was responsible for the prefusion-like antibody reactivity profile, alanine mutations were introduced in HRB. Although introduction of alanine residues in HRB inhibited the formation of the 6HB, the exposure of postfusion-specific antigenic site I was not prevented. In conclusion, proteins that are not able to form the 6HB, due to mutation of HRB, may still display postfusion-specific antigenic site I. Replacement of HRB by the GCN4 trimerization domain in a non-cleaved soluble F protein resulted, however, in a protein with prefusion-like characteristics, suggesting that this HRB-lacking protein may represent a potential prefusion F protein subunit vaccine candidate.

Medienart:

E-Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

PloS one - 10(2015), 6 vom: 28., Seite e0130829

Sprache:

Englisch

Beteiligte Personen:

Widjaja, Ivy [VerfasserIn]
Rigter, Alan [VerfasserIn]
Jacobino, Shamir [VerfasserIn]
van Kuppeveld, Frank J M [VerfasserIn]
Leenhouts, Kees [VerfasserIn]
Palomo, Concepción [VerfasserIn]
Melero, Jose A [VerfasserIn]
Leusen, Jeanette H W [VerfasserIn]
Haijema, Bert Jan [VerfasserIn]
Rottier, Peter J M [VerfasserIn]
de Haan, Cornelis A M [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Neutralizing
Antibodies, Viral
Journal Article
Recombinant Proteins
Research Support, Non-U.S. Gov't
Viral Fusion Proteins

Anmerkungen:

Date Completed 23.03.2016

Date Revised 13.11.2018

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0130829

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM250273535